Breast CancerBreast CancerCancerCancerDisease AreaEventsFundraisingNews & EventsOvarian Cancer
1000 walkers raise over $1.45m for women’s cancer research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Disease Area, Events, Fundraising, News & Events, Ovarian CancerTaking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…
Molecular Endocrinology and PharmacologyNews & Events
Biodesign program wins national award for excellence
By Richard Schoonraad | Molecular Endocrinology and Pharmacology, News & EventsA program that provides industry engagement opportunities and training in biomedical design thinking, while giving industry access to research talent has won a national award. iPREP Biodesign, administered by The…
CancerCancerCancer and Cell BiologyGenetic DiseaseGenetic DiseaseGenome Biology and GeneticsLabNews & EventsOvarian CancerResearchTumours
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetics, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
News & Events
Excitement is palpable among Harry Perkins Institute researchers as they progress the approval stages of a drug that may have the damaging peripheral artery disease on the run. First published…
Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
FundingFundraisingMedia ReleasesNews & EventsPerkins Events
Fundraising value recognised with two national awards
By Richard Schoonraad | Funding, Fundraising, Media Releases, News & Events, Perkins EventsPerth’s Harry Perkins Institute of Medical Research is very proud to announce it brought home two category awards from the Fundraising Institute of Australia’s National Awards for Excellence in Fundraising,…
Epigenetics and Genomics LaboratoryGenetic DiseaseMedia ReleasesMusclesNeurogenetic DiseasesNews & EventsResearch
Support needed for doctors offering couples genetic testing
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Media Releases, Muscles, Neurogenetic Diseases, News & Events, ResearchAs the number of genetic abnormalities that can be identified in pre and post pregnancy tests reaches the thousands, a national project has been launched to assist doctors as they…
Cancer Centre NewsMedia ReleasesNews & Events
Former Federal Minister joins Perkins Board
By Richard Schoonraad | Cancer Centre News, Media Releases, News & EventsFormer Australian Government Minister, the Hon Ben Morton, has been appointed to the Board of the Harry Perkins Institute of Medical Research. Between 2016 and 2022, he represented the electorate…
